Walgreens Medication Error Verdict of $33M Upheld on Appeal

A $33.3 million verdict awarded in a wrongful death lawsuit against Walgreens pharmacy over a medication error has been upheld on appeal by a Florida court. 

The pharmacy malpractice lawsuit was filed by the family of Beth Hippely, who died in January 2007. According to a report in The Ledger, Hippely’s family sued Walgreens, alleging that a teenaged pharmacy technician accidentally gave her a blood thinner dosage that was ten times more powerful than she had been prescribed.

The drug, Warfarin, had been prescribed to Hippely since 2002 as part of her breast cancer treatment. The pharmacy error caused her to suffer a cerebral hemorrhage and paralysis before her death.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

A Florida jury ruled in the family’s favor at trial for the wrongful death lawsuit in August 2007, awarding the $33.3 million, but Walgreen’s appealed the verdict. Last month, the 2nd District Court of Appeals in Lakeland, Florida affirmed the lower court’s decision and upheld the verdict and the award.

According to a 2006 report by the National Academies of Science’s Institute of Medicine, there are about 1.5 million medication errors every year which result in injuries. These mistakes are largely preventable and could be caused by a doctor prescribing the medication incorrectly, the pharmacy filling the wrong dosage or by nurses dispensing a different patient’s drugs.

0 Comments

"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer
Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer "Representative" (Posted 3 days ago)

Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.